Coronary microcirculation in nonculprit vessel territory in reperfused acute myocardial infarction.


Journal

Microvascular research
ISSN: 1095-9319
Titre abrégé: Microvasc Res
Pays: United States
ID NLM: 0165035

Informations de publication

Date de publication:
05 2023
Historique:
received: 13 12 2022
revised: 13 01 2023
accepted: 31 01 2023
pubmed: 6 2 2023
medline: 15 3 2023
entrez: 5 2 2023
Statut: ppublish

Résumé

There is an ongoing debate on the extension of reperfusion-related microvascular damage (MVD) throughout the remote noninfarcted myocardial regions in patients with ST-elevation myocardial infarction (STEMI) that undergo primary percutaneous intervention (pPCI). The aim of this study was to elucidate the impact of reperfusion on remote microcirculatory territory by analyzing hemodynamic alterations in the nonculprit-vessel in relation to reperfusion. A total of 20 patients with STEMI undergoing pPCI were included. Peri-reperfusion temporal changes in hemodynamic parameters were obtained in angiographically normal nonculprit vessels before and 1-h after reopening of the culprit vessel. Intracoronary pressure and flow velocity data were compared using pairwise analyses (before and 1-h after reperfusion). In the non-culprit vessel, compared to the pre-reperfusion state, mean resting average peak velocity (33.4 ± 9.4 to 25.0 ± 4.9 cm/s, P < 0.001) and mean hyperemic average peak velocity (53.5 ± 14.4 to 42.1 ± 10.66 cm/s, P = 0.001) significantly decreased; whereas baseline (3.2 ± 1.0 to 4.0 ± 1.0 mmHg.cm Reperfusion-related microvascular injury extends to involve remote myocardial territory in relation to the magnitude of the adjacent infarction and infarct-zone MVD. (GUARD Clinical TrialsNCT02732080).

Sections du résumé

BACKGROUND
There is an ongoing debate on the extension of reperfusion-related microvascular damage (MVD) throughout the remote noninfarcted myocardial regions in patients with ST-elevation myocardial infarction (STEMI) that undergo primary percutaneous intervention (pPCI). The aim of this study was to elucidate the impact of reperfusion on remote microcirculatory territory by analyzing hemodynamic alterations in the nonculprit-vessel in relation to reperfusion.
METHODS
A total of 20 patients with STEMI undergoing pPCI were included. Peri-reperfusion temporal changes in hemodynamic parameters were obtained in angiographically normal nonculprit vessels before and 1-h after reopening of the culprit vessel. Intracoronary pressure and flow velocity data were compared using pairwise analyses (before and 1-h after reperfusion).
RESULTS
In the non-culprit vessel, compared to the pre-reperfusion state, mean resting average peak velocity (33.4 ± 9.4 to 25.0 ± 4.9 cm/s, P < 0.001) and mean hyperemic average peak velocity (53.5 ± 14.4 to 42.1 ± 10.66 cm/s, P = 0.001) significantly decreased; whereas baseline (3.2 ± 1.0 to 4.0 ± 1.0 mmHg.cm
CONCLUSION
Reperfusion-related microvascular injury extends to involve remote myocardial territory in relation to the magnitude of the adjacent infarction and infarct-zone MVD. (GUARD Clinical TrialsNCT02732080).

Identifiants

pubmed: 36739961
pii: S0026-2862(23)00021-3
doi: 10.1016/j.mvr.2023.104495
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02732080']

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104495

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Murat Sezer (M)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; Acibadem International Hospital, Istanbul, Turkey. Electronic address: sezermr@gmail.com.

Ahmet Tas (A)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Zeynep G Demirtakan (ZG)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Christopher J Broyd (CJ)

The Prince Charles Hospital, Chermside Brisbane, Australia.

Alp Ozcan (A)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Hakan Hasdemir (H)

Department of Cardiology, School of Medicine, Acibadem University, Istanbul, Turkey.

Mehmet Kocaaga (M)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Irem Sezer (I)

Department of Cardiology, School of Medicine, Acibadem University, Istanbul, Turkey.

Mehmet R Sonsoz (MR)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Adem Atici (A)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Ilke Ozcan (I)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Berrin Umman (B)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Zehra Bugra (Z)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Justin E Davies (JE)

National Heart & Lung Institute, Hammersmith Campus, Imperial College London, UK.

Javier Escaned (J)

Department of Cardiology, Hospital Clínico San Carlos IDISSC, Universidad Complutense de Madrid, Madrid, Spain.

Niels van Royen (N)

Department of Cardiology, Radboud University Medical Center, the Netherlands.

Sabahattin Umman (S)

Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH